Purple Biotech PPBT Cash Flow Statement (2014-2026)

NASDAQ PPBT
$1.15 +0.06 (+5.99%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Purple Biotech Quarterly Cash Flow Statement

Periods 36 quarters
Latest Jun 2026

Purple Biotech reported cash from operations of -$2.50M and free cash flow of -$2.50M for the quarter ended Jun 2026, down 62.1% year over year. This cash flow statement covers 36 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2014 Dec2014 Sep2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
3.15M5.11M-7.32M-3.55M-4.85M-6.04M-4.90M-5.16M-5.06M-4.86M-3.78M-2.42M-0.67M-0.42M-0.46M-1.09M-1.31M-23.64M-0.09M0.44M
Depreciation and DepletionDep. & Depletion
0.06M0.06M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.05M0.05M0.06M0.05M0.07M0.07M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.06M0.06M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.05M0.05M0.06M0.05M0.07M0.07M
Share-based CompensationStock Comp.
0.39M0.31M0.31M0.56M0.71M0.84M0.75M0.49M0.45M0.18M0.27M0.22M0.13M-0.03M0.09M0.06M0.20M-0.04M0.09M0.07M
Cash from Discontinued OperationsCash from Discont. Ops
-0.03M-0.37M
Other non-cash itemsOther Non-Cash
-0.05M0.01M-0.02M-0.04M-0.23M-0.56M-0.22M0.03M-0.69M-1.41M-0.69M-0.98M-1.47M-0.60M-0.95M-0.15M-0.07M0.20M-2.16M-1.74M
Change in Working Capital
Change in Account PayablesChange Payables
-0.14M-0.28M0.17M-0.26M1.62M-0.74M0.25M-0.88M1.04M0.92M-0.05M-0.44M-1.14M-0.45M-0.59M-0.23M-0.02M1.29M-1.24M-0.51M
Change in Other Operating AssetsOther Assets Change
-0.11M-0.12M-1.13M0.85M0.16M0.44M-0.33M0.21M0.34M-0.04M-0.21M0.05M0.14M-0.07M-0.25M0.04M0.07M-0.02M-0.08M-0.13M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.08M1.20M2.73M-1.31M-0.93M1.64M-1.50M0.03M0.21M0.18M-0.67M-0.66M-0.35M-0.67M0.13M-0.23M0.00M0.31M0.30M-0.70M
Other Working Capital ChangesOther WC Changes
0.03M1.32M3.87M-2.15M-1.09M1.20M-1.17M-0.18M-0.13M0.22M-0.46M-0.71M-0.49M-0.60M0.38M-0.27M-0.07M0.32M0.38M-0.57M
Cash from OperationsCash from Ops.
-2.91M-3.54M-5.20M-3.70M-3.62M-4.21M-6.06M-5.22M-3.66M-4.98M-5.08M-3.98M-3.30M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M-2.50M
Investing Activities
Capital ExpendituresCapex
-0.01M0.23M-0.01M-0.01M-0.01M0.05M0.00M0.00M0.00M0.01M
Change in Property, Plant and EquipmentChange in PP&E
0.01M-0.23M0.01M0.01M0.01M-0.05M0.00M0.00M0.00M-0.01M
Change in IntangiblesChange Intangibless
-0.20M0.00M0.40M
Acquisitions
-3.55M7.10M
Net of Acquisitions & DivestmentsNet Acquisitions
3.55M-7.10M
Sale and Maturity of InvestmentsInvestments Sold
20.30M-6.00M15.80M0.00M0.00M-0.01M0.00M0.00M0.00M
Change in Acquisitions & DivestmentsChange Acquisitions
12.06M0.14M-2.50M0.02M0.00M22.14M-0.01M
Other Investing ActivitiesOther investing
0.18M0.06M0.13M0.01M0.18M0.35M0.20M0.13M0.08M0.13M0.08M0.08M0.23M0.04M0.05M0.05M0.51M0.05M0.01M
Cash from Investing ActivitiesCash from Investing
1.58M5.06M17.72M-5.98M0.18M8.00M12.60M0.20M1.01M0.07M0.31M0.09M0.07M0.04M0.26M0.11M0.37M-0.10M0.05M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Short-Term Debt issuancesST Debt Issuance
0.00M-0.01M
Current Debt
0.00M-0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.00M-0.01M
Change in Capital Stock
Common Stock IssuedStock Issued
0.56M
Net Shares Issued and RepurchasedNet Shares Issued
0.56M
Net Equity Issued and RepurchasedNet Equity Issued
0.56M
Other financing activitiesOther financing
-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.66M-0.05M-0.05M-0.22M-0.43M-0.05M-0.04M0.64M3.16M-0.06M-0.07M
Cash from Financing ActivitiesCash from Financing
-0.06M0.48M0.16M0.29M0.57M0.09M0.26M0.37M0.57M4.25M0.27M0.43M2.13M3.94M0.10M0.37M5.57M0.30M-0.06M2.12M
Additional items
Exchange Rate EffectFX Effect
0.00M-0.01M-0.03M-0.15M-0.06M0.08M0.05M-0.02M-0.02M0.05M0.00M-0.01M0.00M-0.01M0.04M-0.02M0.00M-0.01M0.05M
Change in Cash
-1.42M1.79M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M-0.38M
Ending Cash Balance
9.12M11.25M23.54M14.01M11.07M10.89M21.88M17.20M15.10M15.03M9.99M6.52M5.44M14.49M5.77M4.74M9.59M7.40M5.57M5.24M
Free Cash FlowFCF
-2.90M-3.77M-5.19M-3.69M-3.62M-4.27M-6.06M-5.22M-3.66M-4.99M-5.08M-3.98M-3.30M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M-2.50M
Net Cash FlowNCF
-1.39M2.00M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M-0.38M
Interest Paid
-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M0.08M-0.01M-0.01M0.01M0.03M-0.01M0.00M

Purple Biotech Cash Flow Statement API

Pull Purple Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PPBT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY